Your browser doesn't support javascript.
Screening for COVID-19 in Symptomatic Cancer Patients in a Cancer Hospital.
Fujiwara, Yu; Sato, Yasuyoshi; Wang, Xiaofei; Oikado, Katsunori; Sato, Yoshinao; Fukuda, Naoki; Enokida, Taisuke; Takeda, Koichi; Ohkushi, Daisuke; Hayama, Brian; Egi, Yoko; Tokai, Yoshitaka; Yamada, Yumi; Nakajima, Yuki; Kubota, Motoko; Haruki, Satomi; Shimizu, Takako; Uchida, Yasuko; Utsugi, Kuniko; Ito, Yoshinori; Ohno, Shinji; Takahashi, Shunji; Tsuchida, Tomohiro.
  • Fujiwara Y; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan; Department of Medicine, Ichan School of Medicine at Mount Sinai, Mount Sinai Beth Israel, 281 1st Avenue, New York, NY 10003, USA.
  • Sato Y; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Wang X; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Oikado K; Diagnostic Imaging Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Sato Y; Diagnostic Imaging Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Fukuda N; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Enokida T; Department of Infectious Diseases, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Takeda K; Department of Infectious Diseases, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Ohkushi D; Department of Infectious Diseases, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Hayama B; Department of Infectious Diseases, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Egi Y; Cancer Screening Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Tokai Y; Cancer Screening Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Yamada Y; Cancer Screening Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Nakajima Y; Cancer Screening Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Kubota M; Cancer Screening Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Haruki S; Cancer Screening Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Shimizu T; Cancer Screening Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Uchida Y; Cancer Screening Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Utsugi K; Cancer Screening Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Ito Y; Department of Chemotherapy, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Ohno S; Department of Breast Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
  • Takahashi S; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan. Electronic address: s.takahashi-chemotherapy@jfcr.or.jp.
  • Tsuchida T; Cancer Screening Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 1358550, Japan.
Cancer Cell ; 38(5): 609-610, 2020 11 09.
Article in English | MEDLINE | ID: covidwho-813502
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Cancer Care Facilities / Mass Screening / Coronavirus Infections / Clinical Laboratory Techniques / Betacoronavirus / Neoplasms Type of study: Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: Cancer Cell Journal subject: Neoplasms Year: 2020 Document Type: Article Affiliation country: J.ccell.2020.09.017

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Cancer Care Facilities / Mass Screening / Coronavirus Infections / Clinical Laboratory Techniques / Betacoronavirus / Neoplasms Type of study: Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: Cancer Cell Journal subject: Neoplasms Year: 2020 Document Type: Article Affiliation country: J.ccell.2020.09.017